Advertisement
Advertisement

BHVN

BHVN logo

Biohaven Ltd.

10.98
USD
Sponsored
+0.97
+9.69%
Apr 17, 16:00 UTC -4
Closed
exchange

After-Market

10.96

-0.02
-0.22%

BHVN Earnings Reports

Positive Surprise Ratio

BHVN beat 5 of 14 last estimates.

36%

Next Report

Date of Next Report
May 08, 2026
Estimate for Q1 26 (Revenue/ EPS)
$599.76K
/
-$0.85
Implied change from Q4 25 (Revenue/ EPS)
--
/
-29.75%
Implied change from Q1 25 (Revenue/ EPS)
--
/
-60.83%

Biohaven Ltd. earnings per share and revenue

On Mar 02, 2026, BHVN reported earnings of -1.21 USD per share (EPS) for Q4 25, beating the estimate of -1.31 USD, resulting in a 8.00% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.65% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of -0.85 USD, with revenue projected to reach 599.76 thousand USD, implying an decrease of -29.75% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Apr 08, 2026 For Q1 26
Estimate
-$0.76
Actual
-$0.79
Surprise
-2.68%
logo
NovaBridge Biosciences - ADR
Report Date
Apr 07, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.28
Surprise
-421.58%
logo
KALA BIO, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$1.46
Actual
-$0.67
Surprise
+54.38%
logo
Scilex Holding Company Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$0.47
Actual
-$2.21
Surprise
-360.99%
logo
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
logo
Quince Therapeutics, Inc. Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$1.92
Actual
-$7.10
Surprise
-268.68%
logo
GeoVax Labs, Inc. New
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$6.29
Actual
$0.00
Surprise
+99.92%
FAQ
For Q4 2025, Biohaven Ltd. reported EPS of -$1.21, beating estimates by 8%, and revenue of $0.00, 0% as expectations.
The stock price moved down -9.65%, changed from $11.81 before the earnings release to $10.67 the day after.
The next earning report is scheduled for May 08, 2026.
Based on 11 analysts, Biohaven Ltd. is expected to report EPS of -$0.85 and revenue of $599.76K for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement